glp-1 obesity drug news today oct 23 2025 Weight-loss drugs such as Ozempic were in the headlines a lot in – and patent protections for these drugs expire in some countries in 2026. In this edition of #PeriodicGraphics in @ Weight-loss drugs such as Ozempic

Although rare, associations with nonarteritic anterior ischemic optic neuropathy, pancreatitis, medullary thyroid carcinoma, and acute kidney injury (AKI) have been reported, primarily through pharmacovigilance and case-based evidence

Learn benefits, risks, and how Isya Aesthetics creates personalized treatment plans

95% CI 0.90, 1.01) and cerebrovascular events (HR 0.99

Safran SafrInside : Saffron, derived from the stigmas of the Crocus sativus flower, is a precious spice renowned for its unique properties

not using GLP-1 receptor agonists had significantly lower relative risks for mortality and respiratory failure, according to a presentation at the CHEST Annual Meeting.In a retrospective study, Saud Alawad, MBBS, third-year internal medicine resident at West Virginia University, and colleagues analyzed adults with a group 1 PAH

Perhaps you've heard of Jardiance and Ozempic and want to learn how they are similar and different